Cupertino, CA, United States of America

Jian-Rui Wang


Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jian-Rui Wang: Pioneering Innovations in Immunotherapy and Polypeptides

Introduction:

Jian-Rui Wang, a skilled inventor hailing from Cupertino, CA, has made significant contributions to the fields of immunotherapy and polypeptide research. With an impressive portfolio of four patents, Wang's latest inventions focus on CD84-like polypeptides and their applications in therapy and diagnosis. Let us explore his groundbreaking work in further detail.

Latest Patents:

Wang's recent patents include "Methods and materials relating to CD84-like polypeptides and polynucleotides." This invention encompasses novel polynucleotides and polypeptides, along with their variants and mutants, that correspond to a human secreted CD84-like polypeptide. These discoveries contribute to advancements in immunotargeting and the production of therapeutic CD84-like polypeptides. Furthermore, the invention describes diagnostic applications involving specific antibodies designed for these polypeptides.

Another groundbreaking patent by Wang focuses on "Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells." This method highlights the potential of immunotargeting CD84Hy1-expressing cells, such as cancer cells, for therapeutic purposes. The invention demonstrates how CD84Hy1 polypeptides, corresponding nucleic acids, and anti-CD84Hy1 antibodies can be employed to eliminate or inhibit the growth of cancer cells expressing CD84Hy1 protein. Additionally, it outlines methods for diagnosing disorders associated with CD84Hy1 protein-expressing cells.

Career Highlights:

During his illustrious career, Wang has worked with renowned companies in the biotechnology sector. He contributed his expertise to Nuvelo, Inc., a company committed to the discovery and development of innovative therapies for serious diseases. Wang's remarkable work at Nuvelo, Inc. has likely influenced the field of immunotherapy significantly. He also made notable contributions to Hyseq, Inc., a company specializing in genomics-based drug discovery.

Collaborations:

Wang has had the privilege of collaborating with accomplished individuals in his field. Notably, he has worked alongside Y Tom Tang, a prominent figure in the biotechnology sector whose expertise spans genomics and pharmacogenomics. Another collaborator is Chenghua Liu, a leading name in the field of cancer research. These collaborations have likely enriched Wang's research and contributed to his inventive work.

Conclusion:

Jian-Rui Wang's contributions to the fields of immunotherapy and polypeptide research are truly remarkable. Through his inventive patents on CD84-like polypeptides and their applications in therapy and diagnosis, he has significantly advanced the possibilities in immunotargeting and the treatment of disorders associated with CD84Hy1 protein-expressing cells. His collaborations with esteemed coworkers have further enhanced his contributions to the field. Wang's work is an excellent example of the innovative research carried out by inventors in the biotechnology sector, aiming to improve the lives of many through groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…